Ledger.Open graph →
SEC Form D · filed February 17, 2015

Cidara Therapeutics, Inc

Offering
$42.0M
Sold
$42.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Paul R. Daruwala · San Diego, CAExecKen R. Bartizal · San Diego, CAExecScott M. Rocklage · San Diego, CADirectorJeffrey Stein · San Diego, CAExec · DirectorKevin Forrest · San Diego, CAExecDan Burgess · San Diego, CADirectorNina Kjellson · San Diego, CADirectorPatrick Heron · Canton, MADirectorJeff Lebrun · Seattle, WADirectorCorey M. Steffek · Boston, MAExec · DirectorKevin Forrest · San Diego, CAExecGary Kelleher · AUSTIN, TXExecSteve Elms · New York, NYDirectorTed Schroeder · San Diego, CADirectorDirk Thye · San Diego, CAExecKevin Judice · Menlo Park, CADirectorKeith Crandell · Boston, MAExec · DirectorGlynn Bloomquist · AUSTIN, TXDirectorPepe Zevada · AUSTIN, TXExecSeth Anon · Manhattan Beach, CAExecMarc Lehmann · Miami Beach, FLExecSteve Elms · San Diego, CADirectorDan Burgess · San Diego, CADirectorTed Schroeder · San Diego, CADirectorDirk Thye · San Diego, CAExecKevin Judice · Menlo Park, CADirectorNina Kjellson · Menlo Park, CADirectorPatrick Heron · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗